Jain M - Search Results

1

The relationship between sweat chloride levels and mortality in cystic fibrosis varies by individual genotype.

Espel JC, Palac HL, Bharat A, Cullina J, Prickett M, Sala M, McColley SA, Jain M. Espel JC, et al. Among authors: jain m. J Cyst Fibros. 2018 Jan;17(1):34-42. doi: 10.1016/j.jcf.2017.11.002. Epub 2017 Dec 6. J Cyst Fibros. 2018. PMID: 29221674 Free article.

2

Type III secretion phenotypes of Pseudomonas aeruginosa strains change during infection of individuals with cystic fibrosis.

Jain M, Ramirez D, Seshadri R, Cullina JF, Powers CA, Schulert GS, Bar-Meir M, Sullivan CL, McColley SA, Hauser AR. Jain M, et al. J Clin Microbiol. 2004 Nov;42(11):5229-37. doi: 10.1128/JCM.42.11.5229-5237.2004. J Clin Microbiol. 2004. PMID: 15528719 Free PMC article.

3

Cystic fibrosis patients have poor sleep quality despite normal sleep latency and efficiency.

Jankelowitz L, Reid KJ, Wolfe L, Cullina J, Zee PC, Jain M. Jankelowitz L, et al. Among authors: jain m. Chest. 2005 May;127(5):1593-9. doi: 10.1378/chest.127.5.1593. Chest. 2005. PMID: 15888833

4

Evolution of Pseudomonas aeruginosa type III secretion in cystic fibrosis: a paradigm of chronic infection.

Jain M, Bar-Meir M, McColley S, Cullina J, Potter E, Powers C, Prickett M, Seshadri R, Jovanovic B, Petrocheilou A, King JD, Hauser AR. Jain M, et al. Transl Res. 2008 Dec;152(6):257-64. doi: 10.1016/j.trsl.2008.10.003. Epub 2008 Oct 31. Transl Res. 2008. PMID: 19059160 Free PMC article.

5

Risk factors for aminoglycoside ototoxicity in adult cystic fibrosis patients.

O'Donnell EP, Scarsi KK, Scheetz MH, Postelnick MJ, Cullina J, Jain M. O'Donnell EP, et al. Among authors: jain m. Int J Antimicrob Agents. 2010 Jul;36(1):94-5. doi: 10.1016/j.ijantimicag.2010.02.018. Epub 2010 Apr 10. Int J Antimicrob Agents. 2010. PMID: 20382508 No abstract available.

6

Clinical significance of microbial infection and adaptation in cystic fibrosis.

Hauser AR, Jain M, Bar-Meir M, McColley SA. Hauser AR, et al. Among authors: jain m. Clin Microbiol Rev. 2011 Jan;24(1):29-70. doi: 10.1128/CMR.00036-10. Clin Microbiol Rev. 2011. PMID: 21233507 Free PMC article. Review.

7

Efficacy of β-lactams as single agents for treating severe pulmonary exacerbations during pregnancy in cystic fibrosis.

Prickett M, Jain M. Prickett M, et al. Among authors: jain m. Am J Respir Crit Care Med. 2012 Dec 15;186(12):1310-1. doi: 10.1164/ajrccm.186.12.1310. Am J Respir Crit Care Med. 2012. PMID: 23250504 No abstract available.

8

Gene therapy in cystic fibrosis.

Prickett M, Jain M. Prickett M, et al. Among authors: jain m. Transl Res. 2013 Apr;161(4):255-64. doi: 10.1016/j.trsl.2012.12.001. Epub 2012 Dec 26. Transl Res. 2013. PMID: 23273902 Review.

9

Update in cystic fibrosis 2013.

Jain M, Goss CH. Jain M, et al. Am J Respir Crit Care Med. 2014 May 15;189(10):1181-6. doi: 10.1164/rccm.201402-0203UP. Am J Respir Crit Care Med. 2014. PMID: 24832742 No abstract available.

10

Aminoglycoside resistance of Pseudomonas aeruginosa in cystic fibrosis results from convergent evolution in the mexZ gene.

Prickett MH, Hauser AR, McColley SA, Cullina J, Potter E, Powers C, Jain M. Prickett MH, et al. Among authors: jain m. Thorax. 2017 Jan;72(1):40-47. doi: 10.1136/thoraxjnl-2015-208027. Epub 2016 Jun 20. Thorax. 2017. PMID: 27325751 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

4,246 results

Search Page